BioPorto Diagnostics and Qiagen have validated BioPorto’s generic Rapid Assay Device (gRAD) lateral flow platform on Qiagen’s ESEQuant LR3 Lateral Flow System. The firms said combining gRAD with the ...

Diagnostic testing has become an essential aspect in a wide variety of settings. Testing assists in the identification of risk factors such as cholesterol levels for coronary disease risk.

QIAGEN N.V. announced an agreement with Lepu Medical Technology (Beijing) Co., Ltd., a leading medical device company in China, to provide QIAGEN’s ESEQuant Lateral Flow System for use in emergency ...

Add Yahoo as a preferred source to see more of our stories on Google. As a result of the rapidly-spreading Omicron variant, Covid case numbers have continued to rise across the UK in record numbers, ...

In this interview, News-Medical talks to Andre Alfaro from nanoComposix (now a Fortis Life Sciences Company) about the possibilities lateral flow assays offer in both the present and potential ...

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...